Top Story

Adults with previous nonmelanoma skin cancer more likely to use sun protection, but still sunburn

May 25, 2016

While adults with previous nonmelanoma skin cancer were more likely to practice sun protection compared with people without a history of skin cancer, they reported similar relative odds of recent sunburn, according to published study results.

Researchers studied self-reported data from the 2005 and 2010 National Health Interview Surveys of non-Hispanic white adults, including 758 with previous nonmelanoma skin cancer (NMSC) and 34,161 without NMSC. Respondents were asked how long they stayed in the shade, wore a hat to shade their face, ears and neck, wore a long-sleeved shirt and if they used sunscreen while outside on a warm, sunny day for more than 1 hour.

In the Journals

Women with new-onset AF at elevated risk for cancer

May 25, 2016
In a cohort of healthy women at baseline, those who developed atrial fibrillation had elevated risk for cancer after their atrial fibrillation diagnosis, according to…

Five treatment advances for children with sickle cell disease

May 25, 2016
Patients with sickle cell disease show signs of disease during the first year of life.Symptoms and complications are different for each person. Treatment options vary…
In the Journals

Physicians call for universal, single-payer health care system

May 25, 2016
In an editorial published in the American Journal of Public Health, researchers outlined a proposal to overhaul the nation’s current health care system and…
FDA News

FDA approves first CMV test for hematopoietic stem cell transplant recipients

May 25, 2016
The FDA approved the first in vitro diagnostic test used to monitor cytomegalovirus treatment in hematopoietic stem cell transplant recipients, according to a press…
More News Headlines »

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
Meeting News Coverage

VIDEO: Liquid biopsy technology a ‘major advance’ but still requires validation

May 5, 2016
More »
AACR Annual Meeting

AACR Annual Meeting

CME Video

NSCLC Treatment on Target: Examining New Evidence and Advances

This activity is supported by an educational grant from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Eighty five percent of lung cancers are non-small…
More »
Current Issues
View the Current Issue
HemOnc Today